Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study

Published 2013 View Full Article

Authors

Keywords

Journal

ANTIVIRAL THERAPY

Volume 19, Issue 2, Pages 141-147

Publisher

International Medical Press

Online

2013-08-28

DOI

10.3851/imp2681

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

ANTIVIRAL THERAPY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Ask a Question. Answer a Question.